Export

Betamethasone
Essential medicine status
Section:
13. Dermatological medicines (topical) 13.3. Dermatological medicines (topical) > Anti-inflammatory and antipruritic medicines
ATC codes: D07AC01
EMLc
Indication
Dermatitis or eczema ICD11 code: EA8Z
INN
Betamethasone
Medicine type
Chemical agent
List type
Core
Formulations
Local > Topical > Cream: 0.1% (as valerate)
Local > Topical > Ointment: 0.1% (as valerate)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 2007 (TRS 950)
Sex
All
Age
Also recommended for children
Age restriction
Hydrocortisone preferred in neonates.
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Patent information
Patents have expired in most jurisdictions
Wikipedia
Betamethasone
DrugBank
Betamethasone
Summary of evidence and Expert Committee recommendations
The EMLc Subcommittee endorsed the inclusion of topical betamethasone valerate 0.1% (with a square box) on the core list of the EMLc. The Subcommittee also recommended including a warning about the use of more potent topical steroids in small children. An note was included in the listing stating that hydrocortisone is preferred for use in neonates.